HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients

Sleep

Volumn 20, Issue 11, 1997, Pages 1012-1020

  Mignot, E ^a   Hayduk, R ^b   Black, J ^a   Grumet, F C ^c   Guilleminault, C ^a  

^a Stanford Medicine Children s Health   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Cataplexy; DQB1*0602; DR2; DRB1*15; HLA; Narcolepsy; Narcolepsy without cataplexy; REM sleep

Indexed keywords

ADULT; AGED; ARTICLE; CATAPLEXY; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NARCOLEPSY; PRIORITY JOURNAL; REM SLEEP; ADOLESCENT; CLINICAL TRIAL; GENETICS; HAPLOTYPE; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; RACE;

BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; HLA DQ ANTIGEN; MODAFINIL;

ADOLESCENT; ADULT; AGED; BENZHYDRYL COMPOUNDS; CATAPLEXY; CENTRAL NERVOUS SYSTEM STIMULANTS; CONTINENTAL POPULATION GROUPS; FEMALE; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; SEVERITY OF ILLNESS INDEX; SLEEP, REM;

EID: 0031283162     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bassetti C, Aldrich M. Narcolepsy. Neurol Clin 1996;14(3): 545-71.
2. Vogel G. Studies in psychophysiology of dreams. III. The dream of narcolepsy. Arch Gen Psychiatry 1960;3:421-8.
3. Rechschaffen A, Dement W. Studies on the relation of narcolepsy, cataplexy and sleep with low voltage random EEG activity. In: Kety S, Evarts E, Williams H, ed. Sleep and altered states of consciousness. Baltimore: Williams and Wilkins, 1967; 488-505.
4. Thorpy M. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990.
5. Honda Y, Asake A, Tanaka Y, Juji T. Discrimination of narcolepsy by using genetic markers and HLA. Sleep Res 1983;12: 254.
6. Honda Y, Matsuki K. Genetic aspects of narcolepsy. In: Thorpy M, ed. Handbook of sleep disorders. New York: Marcel Dekker, 1990:217-34.
7. Mueller-Eckardt G, Meier-Ewert K, Schendel D, Reinecker F, Multhoff G, Mueller-Eckardt C. HLA and narcolepsy in a German population. Tissue Antigens 1986;28:163-9.
8. Langdon N, Welsh KI, Van Dam M, Vaughan RW, Parkes D. Genetic markers in narcolepsy. Lancet 1984;1178-80.
9. Roth B, Nevsimalova S, Sonka K, et al. A study of occurrence of HLA DR2 in 124 narcoleptics: clinical aspects. Arch Suiss Neurol Psychiat 1988;139(4):41-51.
10. Sachs C, Möller E. The occurence of HLA-RD2 in clinically established narcolepsy. Acta Neurol Scand 1987;75:437-9.
11. Billiard M, Seignalet J, Besset A, Cadihac J. HLA-DR2 and narcolepsy. Sleep 1986;9(1):149-52.
12. Poirier G, Monplaisir J, Décary F, Momège D, Lebrun A. HLA antigens in narcolepsy and idiopathic central nervous. Sleep 1986;9(1):153-8
13. Mignot E, Lin X, Arrigoni J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in caucasian and black Americans. Sleep 1994;17(8):S60-7.
14. Mignot E, Tafti M, Dement W, Grumet FC. Narcolepsy and immunity. Adv Neuroimmunol 1994;5:23-37.
15. Carlander B, Eliaou JF, Billiard M. Autoimmune hypothesis in narcolepsy. Neurophysiol Clin 1993;23:15-22.
16. Matsuki K, Honda Y, Juji T. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies. Tissue Antigens 1987;30:155-60.
17. Neely S, Rosenberg R, Spire J, Antel J, Arnason B. HLA antigens in narcolepsy. Neurology 1987;37:1858-60.
18. Matsuki K, Grumet FC, Lin X, Guilleminault C, Dement WC. DQ rather than DR gene marks susceptibility to narcolepsy. Lancet 1992;339:1052.
19. Mignot E, Kimura A, Latterman A, et al. Extensive HLA class II studies in 58 non DRB1*15(DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997;49:329-41.
20. Ellis MC, Hetisimer AH, Ruddy DA, et al. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy, Immunogenetics 1997;46:410-7.
21. Fry J, U.S. Modafinil in Narcolepsy Multicenter Study Group. Modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1997 (in press).
22. Fernandez-Vina M, Gao X, Moraes M, et al. Alelles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics 1991;34:299-312.
23. Rogers AE, Mehan J, Guilleminault C, Grumet FC, Mignot E. HLA DR15 (DR2) and DQB 1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 1997;48:1550-6.
24. Hayduk R, Flodman PM, Spence MA, Erman MK, Miller MM. HLA haplotypes, polysomnography and pedigrees in a case series of patients with narcolepsy. Sleep 1997 (in press).
25. Mignot E, Won C, Grumet F, Dement W, Guilleminault C. DQB1*0602 negative narcolepsy: a different trigger for cataplexy? Sleep Res 1997;26:434.
26. Honda Y, Juji T, Matsuki K, et al. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 1986;9:133-42.
27. Honda Y, Asaka A, Tanimura M, Furusho T. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology and long term evolution. New York: Raven Press, 1983; 187-99.
28. Guilleminault C. Cataplexy. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum Publications, 1976;125-43.
29. Broughton R. Narcolepsy. In: Thorpy M, ed. Handbook of sleep disorders. New York: Marcel Decker, 1990;197-216.
30. Mignot E, Meehan J, Grumet FC, et al. HLA class II and narcolepsy in 33 multiplex families. Sleep Res 1996;25:303.